Результати пошуку - Kiyoshi Niwa

  • Показ 1 - 9 результатів із 9
Уточнити результати
  1. 1
    Exogenous Aβ1–40 Reproduces Cerebrovascular Alterations Resulting from Amyloid Precursor Protein Overexpression in Mice

    Exogenous Aβ1–40 Reproduces Cerebrovascular Alterations Resulting from Amyloid Precursor Protein Overexpression in Mice за авторством Kiyoshi Niwa, George A. Carlson, Costantino Iadecola

    Опубліковано 2000
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  2. 2
    Cyclooxygenase-1 Participates in Selected Vasodilator Responses of the Cerebral Circulation

    Cyclooxygenase-1 Participates in Selected Vasodilator Responses of the Cerebral Circulation за авторством Kiyoshi Niwa, Cindy Haensel, M. Elizabeth Ross, Costantino Iadecola

    Опубліковано 2001
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  3. 3
    The Cyclooxygenase-2 Inhibitor NS-398 Ameliorates Ischemic Brain Injury in Wild-Type Mice but not in Mice with Deletion of the Inducible Nitric Oxide Synthase Gene

    The Cyclooxygenase-2 Inhibitor NS-398 Ameliorates Ischemic Brain Injury in Wild-Type Mice but not in Mice with Deletion of the Inducible Nitric Oxide Synthase Gene за авторством Masao Nagayama, Kiyoshi Niwa, Tomiko Nagayama, M. Elizabeth Ross, Costantino Iadecola

    Опубліковано 1999
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  4. 4
    Cyclooxygenase-2 Contributes to Functional Hyperemia in Whisker-Barrel Cortex

    Cyclooxygenase-2 Contributes to Functional Hyperemia in Whisker-Barrel Cortex за авторством Kiyoshi Niwa, Eiichi Araki, Scott G. Morham, M. Elizabeth Ross, Costantino Iadecola

    Опубліковано 2000
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  5. 5
    Aβ-peptides enhance vasoconstriction in cerebral circulation

    Aβ-peptides enhance vasoconstriction in cerebral circulation за авторством Kiyoshi Niwa, Valerie A. Porter, Ken Kazama, David N. Cornfield, George A. Carlson, Costantino Iadecola

    Опубліковано 2001
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  6. 6
    Reduced susceptibility to ischemic brain injury and <i>N</i> -methyl- <scp>d</scp> -aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice

    Reduced susceptibility to ischemic brain injury and <i>N</i> -methyl- <scp>d</scp> -aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice за авторством Costantino Iadecola, Kiyoshi Niwa, Shigeru Nogawa, Xueren Zhao, Masao Nagayama, Eiichi Araki, Scott G. Morham, M. Elizabeth Ross

    Опубліковано 2001
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  7. 7
    Short-Term Efficacy (at 12 Weeks) and Long-Term Safety (up to 52 Weeks) of Omega-3 Free Fatty Acids (AZD0585) for the Treatment of Japanese Patients With Dyslipidemia ― A Randomized, Double-Blind, Placebo-Controlled, Phase III Study ―

    Short-Term Efficacy (at 12 Weeks) and Long-Term Safety (up to 52 Weeks) of Omega-3 Free Fatty Acids (AZD0585) for the Treatment of Japanese Patients With Dyslipidemia ― A Randomize... за авторством Koutaro Yokote, Kiyoshi Niwa, Tomomi Hakoda, Fumiki Oh, Yoshitaka Kajimoto, Toshiki Fukui, Hyosung Kim, Yoshinori Noda, Torbjörn Lundström, Toshitaka Yajima

    Опубліковано 2020
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  8. 8
    Aβ1–40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation

    Aβ1–40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation за авторством Kiyoshi Niwa, Linda H. Younkin, Christine Ebeling, Sherry Turner, David Westaway, Steven G. Younkin, Karen H. Ashe, George A. Carlson, Costantino Iadecola

    Опубліковано 2000
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  9. 9
    Safety and efficacy of verinurad, a selective URAT1 inhibitor, for the treatment of patients with gout and/or asymptomatic hyperuricemia in the United States and Japan: Findings from two phase II trials

    Safety and efficacy of verinurad, a selective URAT1 inhibitor, for the treatment of patients with gout and/or asymptomatic hyperuricemia in the United States and Japan: Findings fr... за авторством David Fitzpatrick, Kent Roberson, Kiyoshi Niwa, Takabumi Fujimura, Koji Mori, Jesse Hall, Xiaohong Yan, Zancong Shen, Sha Liu, Yasushi Ito, Scott Baumgartner

    Опубліковано 2018
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: